Avadel Pharmaceuticals
AVDL
#5525
Rank
NZ$1.79 B
Marketcap
$18.63
Share price
2.54%
Change (1 day)
-16.10%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2024 (TTM): -NZ$0.12 Billion

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2023 the company made an earning of -NZ$0.29 Billion a decrease over its 2022 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.12 Billion-58.36%
2023 -NZ$0.29 Billion44.27%
2022 -NZ$0.2 Billion19.64%
2021 -NZ$0.17 Billion1732.84%
2020 -NZ$9.03 Million-86.83%
2019 -NZ$68.52 Million-65.92%
2018 -NZ$0.21 Billion-222.16%
2017 NZ$0.16 B-1053.49%
2016 -NZ$17.26 Million-112.59%
2015 NZ$0.13 B-185.94%
2014 -NZ$0.16 Billion66.04%
2013 -NZ$96.06 Million582.16%
2012 -NZ$14.09 Million-7.6%
2011 -NZ$15.24 Million-2.1%
2010 -NZ$15.57 Million32.52%
2009 -NZ$11.75 Million-64.36%
2008 -NZ$32.97 Million-52.93%
2007 -NZ$70.02 Million5.66%
2006 -NZ$66.27 Million17.86%
2005 -NZ$56.23 Million-375.09%
2004 NZ$20.43 M-406.44%
2003 -NZ$6.67 Million-145.2%
2002 NZ$14.75 M-363.36%
2001 -NZ$5.61 Million-80.62%
2000 -NZ$28.92 Million132.68%
1999 -NZ$12.43 Million-50.34%
1998 -NZ$25.03 Million54.85%
1997 -NZ$16.16 Million-28.35%
1996 -NZ$22.56 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$32.24 Million-75.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion 61.42%๐Ÿ‡บ๐Ÿ‡ธ USA